Edition:
United States

People: Sol Gel Technologies Ltd (SLGL.OQ)

SLGL.OQ on NASDAQ Stock Exchange Global Market

6.99USD
18 Apr 2019
Change (% chg)

$-0.14 (-1.96%)
Prev Close
$7.13
Open
$7.03
Day's High
$7.14
Day's Low
$6.99
Volume
9,833
Avg. Vol
4,312
52-wk High
$10.00
52-wk Low
$5.61

Mamlok, Gilad 

Mr. Gilad Mamlok is Chief Financial Officer of the Company. From August 2015 to January 2017, Mr. Mamlok served as the chief financial officer for Medigus Ltd., a medical device company dual listed on Nasdaq and the Tel Aviv Stock Exchange, or the TASE. From September 2005 to March 2015, Mr. Mamlok served as senior vice president, global finance and accounting of Given Imaging Ltd., a medical device company dual listed on Nasdaq and TASE, acquired by Covidien plc in February 2014. From January 2002 to September 2005, Mr. Mamlok served as chief financial officer of two other medical device companies. Mr. Mamlok holds a Master’s degree in business economics from Tel-Aviv University and a B.A. in economics (magna cum laude) from Tel-Aviv University, Israel.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Awards, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --